LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
The latest regulatory, legal, compliance, and technology news for labs and pathology practices.
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
In this week’s enforcement roundup, the former executive was convicted of healthcare fraud relating to mental health diagnosis and treatment.
A new technology could help protect patients’ privacy when it comes to the use of facial images in medical diagnoses.
Retailer stubs a toe on its way to disrupting health care.
It now appears that Congress is going to dash the lab industry’s hopes yet again by reauthorizing FDA user fees without VALID.
The owner of several clinical labs and other businesses will pay big for the schemes that involved money laundering, kickbacks, and fraud.
According to healthcare groups, the Improving Seniors’ Timely Access to Care Act would help fix problems with current system.
You’ll need a healthcare equity plan to maintain Joint Commission accreditation after Jan. 1.
Biden administration blames the decision on Congress’ failure to provide the additional funding necessary to keep the program going.
Mark Schena was found guilty of defrauding investors, as well as running an illegal kickback and healthcare fraud scheme.
The agency will also allow CLIA labs to use serology and antigen tests without EUA.